Lv3
274 积分 2024-09-09 加入
Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP
7天前
已完结
The use of 18FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini review
10天前
已完结
FAPI PET-guided tumor volume delineation for radiotherapy planning: A comprehensive review across solid tumors
10天前
已完结
Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
12天前
已完结
The future is not always uniform: rethinking radiotherapy through spatial fractionation
13天前
已完结
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial
13天前
已完结
[18F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer
13天前
已完结
The valuable role of dynamic 18F FDG PET/CT-derived kinetic parameter Ki in patients with nasopharyngeal carcinoma prior to radiotherapy: a prospective study
13天前
已完结
Dynamic Total-Body PET Imaging Unfolds [ 11 C]Choline Kinetics and Dosimetry in Primary Hyperparathyroidism
14天前
已关闭
驱动基因阴性非小细胞肺癌多学科诊疗专家共识（2026版）
21天前
已完结
皖公网安备34019202002308
